H.R. 1298 (111th): Pharmaceutical Market Access and Drug Safety Act of 2009

Introduced:
Mar 04, 2009 (111th Congress, 2009–2010)
Status:
Died (Referred to Committee)
See Instead:

S. 1232 (same title)
Reported by Committee — Jun 11, 2009

Sponsor
Robert “Marion” Berry
Representative for Arkansas's 1st congressional district
Party
Democrat
Text
Read Text »
Last Updated
Mar 04, 2009
Length
140 pages
Related Bills
S. 1232 (identical)

Reported by Committee
Last Action: Jun 11, 2009

S. 525 (identical)

Referred to Committee
Last Action: Mar 04, 2009

 
Status

This bill was introduced on March 4, 2009, in a previous session of Congress, but was not enacted.

Progress
Introduced Mar 04, 2009
Referred to Committee Mar 04, 2009
 
Full Title

To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.

Summary

No summaries available.

Cosponsors
36 cosponsors (22D, 14R) (show)
Committees

House Energy and Commerce

Health

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


3/4/2009--Introduced.
Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.
Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.
Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.
Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.
Prohibits manufacturers from:
(1) discriminating against registered exporters or importers;
(2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country;
(3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or
(4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary to educate consumers regarding prescription drug importation.
Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.
Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 1298 (111th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus